We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+45.46%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$167M
AUM Growth
+$59.7M
Cap. Flow
+$30.3M
Cap. Flow %
18.17%
Top 10 Hldgs %
88.4%
Holding
26
New
4
Increased
6
Reduced
6
Closed
4

Top Buys

Rank Stock Value
1
PHAT icon
Phathom Pharmaceuticals
PHAT
+$7.33M
2
MYGN icon
Myriad Genetics
MYGN
+$2.02M
3
PLTR icon
Palantir
PLTR
+$844K
4
PACB icon
Pacific Biosciences
PACB
+$501K
5
BHVN icon
Biohaven
BHVN
+$187K

Top Sells

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$7.44M
2
WGS icon
GeneDx Holdings
WGS
+$2.03M
3
EYPT icon
EyePoint Inc
EYPT
+$1.75M
4
ARDX icon
Ardelyx
ARDX
+$702K
5
WBA
Walgreens Boots Alliance
WBA
+$333K

Sector Composition

Rank Sector Weight
1 Healthcare 72.99%
2 Consumer Discretionary 1.38%
3 Technology 0.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WBA
26
DELISTED
Walgreens Boots Alliance
WBA
– –
-27,500
Closed -$333K
1
2

Similar funds

EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM
CWA
Clearview Wealth Advisors Salem, Oregon $158M AUM 14.25% 1-Year Est. Return
SW
Schulz Wealth Mansfield, Texas $156M AUM 13.29% 1-Year Est. Return

Oracle Investment Management's Q3 2024 Portfolio in Review

As of Q3 2024, Oracle Investment Management held 26 positions worth $167M, up 56% from $107M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Oracle Investment Management deployed $30.3M of net new capital in Q3 2024, opening 4 new positions and adding to 6 existing holdings. Its largest new stake was Palantir: 27,500 shares worth $1.02M.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, down from 85% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was SpringWorks Therapeutics, an estimated $7.44M trimmed.

  • Oracle Investment Management's largest Q3 2024 buy was Palantir: 27,500 shares worth $1.02M.
  • Oracle Investment Management added most to Phathom Pharmaceuticals in Q3 2024, an estimated $7.33M increase.
  • Oracle Investment Management's biggest Q3 2024 reduction was SpringWorks Therapeutics, cutting an estimated $7.44M.
  • Oracle Investment Management fully exited Walgreens Boots Alliance in Q3 2024, selling an estimated $333K.
  • Oracle Investment Management's ten largest holdings make up 88% of its $167M portfolio in Q3 2024.
  • Oracle Investment Management opened 4 new positions and closed 4 in Q3 2024.
  • Oracle Investment Management's portfolio value rose 56% quarter-over-quarter to $167M.

Based on Oracle Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.